D-0285-2022 Class III Terminated

Recalled by Torrent Pharma Inc. — Basking Ridge, NJ

FDA drug recall D-0285-2022 was initiated by Torrent Pharma Inc. on Dec 1, 2021 and is designated Class III. Reason for recall: Superpotent; Hydrochlorothiazide The recall status is terminated (terminated May 12, 2024). Affected quantity: 27,312 Bottles.

Recall details

Product Type
Drugs
Report Date
Dec 22, 2021
Initiation Date
Dec 1, 2021
Termination Date
May 12, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27,312 Bottles

Product description

Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30

Reason for recall

Superpotent; Hydrochlorothiazide

Distribution pattern

Nationwide USA

Code information

Batch: BZ74G001 Exp. 12/2021.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0285-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0285-2022. Report a data issue: hello@regdatalab.com.